Halothane, but not isoflurane, impairs the β-adrenergic responsiveness in rat myocardium

Anesthesiology

Volumn 88, Issue 5, 1998, Pages 1330-1339

  Schotten, Ulrich ^a   Schumacher, Carlos ^a   Sigmund, Martin ^a   Karlein, Christian ^a   Rose, Horst ^b   Kammermeier, Helmut ^b   Sivarajan, Murali ^c   Hanrath, Peter ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Adrenoceptor; Contraction experiments; Radioimmunoassay; Radioligand binding; Volatile anesthetics

Indexed keywords

4 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 2 BENZIMIDAZOLONE; ADRENALIN; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYANOIODOPINDOLOL; CYCLIC AMP; HALOTHANE; IODINE 125; ISOFLURANE; ISOPRENALINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; FEMALE; HEART FUNCTION; INHALATION ANESTHESIA; INOTROPISM; MINIMUM LUNG ALVEOLUS CONCENTRATION; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; RECEPTOR BINDING; SIGNAL TRANSDUCTION;

ADRENERGIC BETA-AGONISTS; ANESTHETICS, INHALATION; ANIMALS; CYCLIC AMP; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; FEMALE; HALOTHANE; HEART; ISOFLURANE; ISOPROTERENOL; MYOCARDIAL CONTRACTION; MYOCARDIUM; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, BETA; SIGNAL TRANSDUCTION;

EID: 0031966281     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-199805000-00025     Document Type: Article

References (37)

1. Rose H, Birker B, Ionescu I, Pöpping S, Fischer Y, Kammermeier H: Negative inotropic effects of volatile anaesthetics and antiarrhythmic drugs in cardiomyocytes: Analysis of contraction and energetics. Pharm Pharmacol Lett 1992; 2:16-9
2. Hirota K, Ito Y, Kuze S, Momose Y: Effects of halothane on electrophysiologic properties and cyclic adenosine 3′,5′-monophosphate content in isolated guinea pig hearts. Anesth Analg 1992; 74:564-9
3. 2+ channel in human myocardium. ANESTHESIOLOGY 1993; 79:332-9
4. Luk HN, Lin CI, Wei J, Chang CL: Depressant effects of isoflurane and halothane on isolated human atrial fibers. ANESTHESIOLOGY 1988; 69:667-76
5. Bosnjak ZJ, Supan FD, Rusch NJ: The effects of halothane, enflurane and isoflurane on calcium current in isolated ventricular cells. ANESTHESIOLOGY 1991; 74:340-5
6. Katsuoka M, Ohnishi ST: Inhalation anaesthetics decrease calcium content of cardiac sarcoplasmatic reticulum. Br J Anaesth 1989; 62:669-73
7. 2+ uptake and release by the sarcoplasmic reticulum in skinned human myocardial fibers. Anesth Analg 1995; 81:52-6
8. Murat I, Ventura-Clapier R, Vassort G: Halothane, enflurane, and isoflurane decrease calcium sensitivity and maximal force in detergent-treated rat cardiac fibers. ANESTHESIOLOGY 1988; 69:892-9
9. Tavernier BM, Adnet PJ, Imbenotte M, Etchrivi TS, Reyford H, Haudecoeur G, Scherpereel P, Krivosic-Horber R: Halothane and isoflurane decrease calcium sensitivity and maximal force in human skinned cardiac fibers. ANESTHESIOLOGY 1994; 80:625-33
10. Thurston TA, Glusman S: Halothane myocardial depression: Interactions with the adenylate cyclase system. Anesth Analg 1993; 76:63-8
11. Seifen AB, Kennedy RH, Seifen E: Effects of volatile anesthetics on response to norepinephrine and acetylcholine in guinea pig atria. Anesth Analg 1991; 73:304-9
12. Hayashi Y, Sumikawa K, Yamatodani A, Kamibayaslii T, Kuro M, Yoshiya I: Myocardial sensitization with subanesthetic concentrations of halothane in dogs. ANESTHESIOLOGY 1991; 74:134-7
13. Johnston RR, Eger EI, Wilson C: A comparative interaction of epinephrine with enflurane, isoflurane and halothane in man. Anesth Analg 1976; 55:709-12
14. Bernstein KJ, Gangat Y, Verosky M, Vulliemoz Y, Triner L: Halotliane effect on beta-adrenergic receptors in canine myocardium. Anesth Analg 1981; 60:401-5
15. Marty J, Nivoche Y, Nimier M, Rocchiccioli C, Luscombe F, Henzel D, Loiseau A, Desmonts JM: The effects of halothane on the human beta-adrenergic receptors of lymphocyte membranes. ANESTHESIOLOGY 1987; 67:974-8
16. Böhm M, Schmidt U, Schwinger RHG, Böhm S, Erdmann E: Effects of halothane on β-adrenoceptors and m-cholinoceptors in human myocardium: radioligand binding and functional studies. J Cardivasc Pharmacol 1993; 21:296-304
17. Gangat Y, Vulliemoz Y, Verosky M, Danilo P, Bernstein K, Triner L: Action of halothane on myocardial adenylate cyclase of rat and cat. Proc Soc Exp Biol Med 1979; 160:154-9
18. Schumacher C, Becker H, Conrads R, Schotten U, Pott S, Kellinghaus M, Sigmund M, Schöndube F, Preusse C, Schulte HD, Hanrath P: Hypertrophic cardiomyopathy: A desensitized cardiac β-adrenergic system in the presence of normal plasma catecholamine concentrations. Naunyn Schmiedeberg's Arch Pharmacol 1995; 351:398-407
19. Anthony BL, Dennison RL, Aronstam RS: Influence of volatile anesthetics on muscarinic regulation of adenylate cyclase activity. Biochem Pharmacol 1990; 40:376-9
20. Fischer Y, Rose H, Kammermeier H: Highly insulin-responsive isolated rat heart muscle cells yielded by a modified isolation method. Life Science 1991; 49:1679-88
21. 2+- and species-dependent systolic and diastolic contractile properties of intact muscle. J Gen Physiol 1986; 88:589-613
22. Kent RS, De Lean A, Lefkowitz RJ: A quantitative analysis of bctaadrenergic receptor interactions: Resolution of high and low affinity states of the receptor by computer modeling of ligand binding data. Mol Pharmacol 1980; 17:14-23
23. 2-adrenoceptors in human right atrium. Circ Res 1983; 53:752-8
24. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 1976; 72:248-54
25. Scatchard G: The attraction of proteins for small molecules and ions. Ann N Y Acad Sci 1949; 51:660-72
26. 125lodocyanopindolol, a new ligand for β-adrenoceptors: Identification and quantification of subclasses of β-adrenoceptors in guinea-pig. Naunyn Schmiedebergs Arch Pharmacol 1981; 317:277-85
27. Weiss JN: The Hill equation revisited: Uses and misuses. FASEB J 1997; 11:835-41
28. 50) of an enzymatic reaction. Biochem Pharmacol 1973; 22:3099-108
29. Wolf WJ, Neal MB, Mathew BP, Bee DE: Comparison of the in vitro depressant effects of isoflurane and halothane anesthesia. ANESTHESIOLOGY 1988; 69:660-6
30. Luk HN, Lin CI, Chang CL, Lee AR: Differential inotropic effects of halothane and isoflurane in dog ventricular tissues. Eur J Pharmacol 1987; 136:409-13
31. Schmidt U, Schwinger RHG, Böhm M: Halothane restores the altered force-frequency relationship in failing human myocardium. ANESTHESIOLOGY 1995; 82:1456-62
32. Schmidt U, Schwinger RHG, Böhm M: Interaction of halothane with inhibitory G-proteins in the human myocardium. ANESTHESIOLOGY 1995; 83:353-60
33. Hanouz JL, Riou B, Massais L, Lecarpentier Y, Coriat P: Interaction of halothane with α- and β-adrenoceptor stimulations in rat myocardium. ANESTHESIOLOGY 1997; 86:147-59
34. De Lean A, Stadel JM, Lefkowitz RJ: A ternary complex model explains the agonist-specific binding properties of the adenylate cyclasecoupled β-adrenergic receptor. J Biol Chem 1980; 255:7108-17
35. Schotten U, Schumacher C, Sigmund M, Rose H, Kammermeier H, Hanrath P: β-adrenoceptor of isolated adult rat cardiomyocytes are not changed by halothane. Eur Heart J 1993; 14(Suppl):299
36. Wheeler DM, Katz A, Rice T, Hansford RG: Volatile anesthetic effects on sarcoplasmic reticulum Ca content and sacrolemmal Ca flux in isolated rat cardiac cell suspensions. ANESTHESIOLOGY 1994; 80:37282
37. Bristow MR, Green RD: Effect of diazoxide, verapamil and compound D600 on isoproterenol and calcium-mediated dose-response relationships in isolated rabbit atrium. Eur J Pharmacol 1977; 45:267-79